Pinnacle Ventures is a private venture capital fund focused on providing debt and equity financing to early-stage companies across technology and healthcare. Pinnacle differentiates itself through the strength and diversity of its team, its creative and flexible financing alternatives and its unique approach to helping its portfolio companies achieve success. More information about Pinnacle Ventures can be found at http://www.pinnacleventures.com
The Malaysian Life Sciences Capital Fund (MLSCF) is a newly formed life sciences venture fund specializing in early stage investments in the areas of agriculture, industrial and healthcare biotechnology. The Fund is co-managed by Malaysian Technology Development Corporation Sdn Bhd (MTDC) and Burrill & Co. More information about The Malaysian Life Sciences Capital Fund (MLSCF) can be found at http://www.mlscf.com.
Burrill & Company is a life sciences merchant bank focused exclusively on companies involved in biotechnology, pharmaceuticals, diagnostics, devices, human healthcare and related medical technologies, nutraceuticals and wellness, agricultural biotechnology, and industrial biotechnology (biomaterials/bioprocesses) with over $950 million under management. Burrill's technical and venture investing competence spans the entire spectrum of life sciences. The expertise of the firm's investment team, strategic partners and Advisory Boards is unparalleled in depth and breadth. In addition, Burrill is a leader in life science strategic partnering, an invaluable practice to build value in portfolio companies and to accelerate their growth and development. This combination of resources and capabilities has helped Burrill develop a unique and highly effective platform for finding and making outstanding life science investments.
VantagePoint Venture Partners provides creative growth strategies and capital to companies transforming global markets. With more than $4.0 billion of capital under management, the Firm invests in entrepreneurial companies at all stages of development in the CleanTech, Healthcare, and Information Technology sectors. VantagePoint partners with talented entrepreneurs who are seeking to build companies that are world-scale in both size and substance. The Firm has created a network of thought leaders and strategic partners with some of the world's leading corporations to provide portfolio companies with a unique advantage to accelerate growth.
Parsons & Whittemore Inc., a privately held company based in Rye Brook, N.Y., was founded in 1853 and acquired by Karl F. Landegger in 1944. Throughout its history, the company has been recognized as a leading turnkey engineer/builder of pulp and paper mills, and has owned and operated some of the world's largest and most efficient pulp facilities, such as the Alabama River Pulp and Alabama Pine Pulp mills in Monroe County, Alabama. It has invested in Cobalt through its investment arm The Whittemore Collection Ltd.
LSP (Life Sciences Partners) is a leading independent venture capital firm, providing private equity financing to early- to mid-stage life-science companies. Since the late 1980s, LSP's management has invested in a large number of highly innovative enterprises, many of which havegrown to become leaders of the global life-science industry. With more than $600 million under management and offices in Amsterdam, Munichand Boston, LSP is one of most experienced specialist life-science investors.
@Ventures provides venture capital and growth resources to early stage clean technology companies. Established in 1995, @Ventures has funded more than 75 companies across a broad range of technology sectors. The firm’s mission – to identify, invest in, and help build high value clean technology companies – is realized through a commitment to providing valuable expertise and financial resources, in partnership with the firm’s portfolio companies. The firm’s leadership team has many years of early-stage experience and industry contacts, enabling the firm to provide mentoring assistance and strategic and tactical advice that can help technology companies achieve their full potential.
Harris & Harris Group, Inc. ® is a publicly traded venture capital firm exclusively focused on investing in companies enabled by nanotechnology and microsystems. With over 30 nanotechnology companies in the portfolio, Harris & Harris Group, Inc., is one of the most active nanotechnology investors in the world. It has funded companies developing nanoscale-enabled solutions in biochemicals, biofuels, solid state lighting, emerging memory devices, printable electronics, photovoltaics, battery technologies, thermal and power management, as well as in various life-science applications of nano-structured materials. Harris & Harris Group has been making venture capital investments since 1984.